European regulator launches ‘solidarity mechanism’ to tackle critical medicines shortages
The voluntary mechanism will allow EU member states to support each other in the event of a critical medicines shortage.
The European Medicines Agency said the 'solidarity mechanism' should only be used “under very limited conditions after [member states] have exhausted all other possibilities”
Westend61 GmbH / Alamy Stock Photo
A ‘solidarity mechanism’ to tackle critical medicines shortages has been launched by the European Medicines Agency (EMA).
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
